ChemoCentryx
Stock
Stock
ISIN: US16383L1061
Ticker: CCXI-RM
US16383L1061
CCXI-RM
Price
Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for ChemoCentryx?
ChemoCentryx's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -1.887. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for ChemoCentryx's stock?
Currently, 1 analysts cover ChemoCentryx's stock, with a consensus target price of $52.00. Analyst ratings provide insights into the stock's expected performance.
What is ChemoCentryx's revenue over the trailing twelve months?
Over the trailing twelve months, ChemoCentryx reported a revenue of $37.20M.
What is the EBITDA for ChemoCentryx?
ChemoCentryx's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$126.82M. EBITDA measures the company's overall financial performance.
What is the free cash flow of ChemoCentryx?
ChemoCentryx has a free cash flow of -$58.97M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does ChemoCentryx have, and what sector and industry does it belong to?
ChemoCentryx employs approximately 178 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
Financials
- EPS (TTM)
- -1.887
- Revenue (TTM)
- $37.20M
- EBITDA (TTM)
- -$126.82M
- Free Cashflow (TTM)
- -$58.97M
Analyst Ratings
The price target is $52.00 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.
- Employees
- 178
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US16383L1061
- Primary Ticker
- CCXI-RM
Knockouts
LSX Data · Fundamentals & EOD data from FactSet